Bank of New York Mellon’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,705
| Closed | -$17K | – | 4269 |
|
|
2025
Q3 | $17K | Hold |
3,705
| – | – | ﹤0.01% | 4163 |
|
|
2025
Q2 | $14.5K | Hold |
3,705
| – | – | ﹤0.01% | 4122 |
|
|
2025
Q1 | $15K | Hold |
3,705
| – | – | ﹤0.01% | 4095 |
|
|
2024
Q4 | $28.1K | Hold |
3,705
| – | – | ﹤0.01% | 4098 |
|
|
2024
Q3 | $89.7K | Hold |
3,705
| – | – | ﹤0.01% | 4019 |
|
|
2024
Q2 | $155K | Hold |
3,705
| – | – | ﹤0.01% | 3985 |
|
|
2024
Q1 | $240K | Sell |
3,705
-548
| -13% | -$27.8K | ﹤0.01% | 3878 |
|
|
2023
Q4 | $192K | Sell |
4,253
-2,087
| -33% | -$95.1K | ﹤0.01% | 3966 |
|
|
2023
Q3 | $277K | Buy |
6,340
+93
| +1% | +$5.45K | ﹤0.01% | 3837 |
|
|
2023
Q2 | $454K | Sell |
6,247
-47
| -0.7% | -$3.82K | ﹤0.01% | 3651 |
|
|
2023
Q1 | $480K | Sell |
6,294
-271
| -4% | -$21.8K | ﹤0.01% | 3511 |
|
|
2022
Q4 | $632K | Buy |
6,565
+2,294
| +54% | +$248K | ﹤0.01% | 3425 |
|
|
2022
Q3 | $482K | Hold |
4,271
| – | – | ﹤0.01% | 3582 |
|
|
2022
Q2 | $542K | Sell |
4,271
-8
| -0.2% | -$703 | ﹤0.01% | 3539 |
|
|
2022
Q1 | $300K | Sell |
4,279
-621
| -13% | -$43.2K | ﹤0.01% | 4021 |
|
|
2021
Q4 | $351K | Hold |
4,900
| – | – | ﹤0.01% | 4008 |
|
|
2021
Q3 | $254K | Sell |
4,900
-4,209
| -46% | -$251K | ﹤0.01% | 4110 |
|
|
2021
Q2 | $564K | Hold |
9,109
| – | – | ﹤0.01% | 3712 |
|
|
2021
Q1 | $674K | Buy |
9,109
+6,682
| +275% | +$641K | ﹤0.01% | 3534 |
|
|
2020
Q4 | $223K | Sell |
2,427
-9,202
| -79% | -$771K | ﹤0.01% | 3943 |
|
|
2020
Q3 | $402K | Hold |
11,629
| – | – | ﹤0.01% | 3589 |
|
|
2020
Q2 | $167K | Hold |
11,629
| – | – | ﹤0.01% | 3840 |
|
|
2020
Q1 | $220K | Hold |
11,629
| – | – | ﹤0.01% | 3715 |
|
|
2019
Q4 | $229K | Hold |
11,629
| – | – | ﹤0.01% | 3880 |
|
|
2019
Q3 | $224K | Hold |
11,629
| – | – | ﹤0.01% | 3879 |
|
|
2019
Q2 | $250K | Sell |
11,629
-181
| -2% | -$5.33K | ﹤0.01% | 3862 |
|
|
2019
Q1 | $355K | Sell |
11,810
-5
| -0% | -$154 | ﹤0.01% | 3679 |
|
|
2018
Q4 | $372K | Hold |
11,815
| – | – | ﹤0.01% | 3623 |
|
|
2018
Q3 | $355K | Hold |
11,815
| – | – | ﹤0.01% | 3774 |
|
|
2018
Q2 | $384K | Hold |
11,815
| – | – | ﹤0.01% | 3748 |
|
|
2018
Q1 | $350K | Hold |
11,815
| – | – | ﹤0.01% | 3742 |
|
|
2017
Q4 | $256K | Sell |
11,815
-6,683
| -36% | -$146K | ﹤0.01% | 3861 |
|
|
2017
Q3 | $396K | Hold |
18,498
| – | – | ﹤0.01% | 3669 |
|
|
2017
Q2 | $387K | Hold |
18,498
| – | – | ﹤0.01% | 3708 |
|
|
2017
Q1 | $420K | Hold |
18,498
| – | – | ﹤0.01% | 3622 |
|
|
2016
Q4 | $370K | Sell |
18,498
-13
| -0.1% | -$262 | ﹤0.01% | 3706 |
|
|
2016
Q3 | $365K | Sell |
18,511
-37
| -0.2% | -$635 | ﹤0.01% | 3677 |
|
|
2016
Q2 | $243K | Hold |
18,548
| – | – | ﹤0.01% | 3827 |
|
|
2016
Q1 | $259K | Hold |
18,548
| – | – | ﹤0.01% | 3699 |
|
|
2015
Q4 | $279K | Sell |
18,548
-400
| -2% | -$5.79K | ﹤0.01% | 3758 |
|
|
2015
Q3 | $300K | Sell |
18,948
-400
| -2% | -$6K | ﹤0.01% | 3772 |
|
|
2015
Q2 | $261K | Sell |
19,348
-964
| -5% | -$12.9K | ﹤0.01% | 3822 |
|
|
2015
Q1 | $266K | Sell |
20,312
-588
| -3% | -$8.66K | ﹤0.01% | 3822 |
|
|
2014
Q4 | $305K | Sell |
20,900
-2,500
| -11% | -$34.6K | ﹤0.01% | 3774 |
|
|
2014
Q3 | $328K | Hold |
23,400
| – | – | ﹤0.01% | 3760 |
|
|
2014
Q2 | $395K | Hold |
23,400
| – | – | ﹤0.01% | 3668 |
|
|
2014
Q1 | $468K | Sell |
23,400
-223
| -0.9% | -$4.23K | ﹤0.01% | 3604 |
|
|
2013
Q4 | $380K | Hold |
23,623
| – | – | ﹤0.01% | 3674 |
|
|
2013
Q3 | $449K | Buy |
23,623
+10,023
| +74% | +$168K | ﹤0.01% | 3560 |
|
|
2013
Q2 | $211K | Buy |
+13,600
| New | +$212K | ﹤0.01% | 3760 |
|
Other funds holding PRPH
SC
SG
CA
Bank of New York Mellon's PRPH Position: Q4 2025 in Review
Bank of New York Mellon sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 3,705 shares — an estimated $17K sold.
Bank of New York Mellon first reported a position in PRPH in Q2 2013 and held it in 50 quarters. The position peaked at $674K in Q1 2021. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.
- Bank of New York Mellon reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
- Bank of New York Mellon sold 3,705 ProPhase Labs shares in Q4 2025, an estimated $17K.
- Bank of New York Mellon first reported a position in ProPhase Labs in Q2 2013 and held it in 50 quarters.
- Bank of New York Mellon's ProPhase Labs position peaked at $674K in Q1 2021.
- 17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.
Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.